Vanguard Personalized Indexing Management LLC Takes Position in Exscientia plc (NASDAQ:EXAI)

Vanguard Personalized Indexing Management LLC acquired a new position in Exscientia plc (NASDAQ:EXAI) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 10,629 shares of the company’s stock, valued at approximately $54,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in EXAI. GAMMA Investing LLC boosted its stake in Exscientia by 112.1% during the first quarter. GAMMA Investing LLC now owns 4,356 shares of the company’s stock worth $25,000 after buying an additional 2,302 shares during the period. China Universal Asset Management Co. Ltd. boosted its position in shares of Exscientia by 76.8% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 9,274 shares of the company’s stock worth $53,000 after purchasing an additional 4,029 shares during the period. Federated Hermes Inc. acquired a new stake in Exscientia in the 2nd quarter valued at approximately $115,000. EntryPoint Capital LLC raised its position in Exscientia by 22.8% in the first quarter. EntryPoint Capital LLC now owns 31,171 shares of the company’s stock valued at $178,000 after purchasing an additional 5,784 shares during the period. Finally, Bank of New York Mellon Corp lifted its stake in Exscientia by 108.8% during the second quarter. Bank of New York Mellon Corp now owns 388,459 shares of the company’s stock worth $1,981,000 after purchasing an additional 202,377 shares in the last quarter. Institutional investors and hedge funds own 41.58% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Barclays reaffirmed an “equal weight” rating and issued a $5.00 target price on shares of Exscientia in a research report on Tuesday, August 13th. TD Cowen reaffirmed a “hold” rating on shares of Exscientia in a research note on Friday, August 9th.

Exscientia Price Performance

EXAI stock opened at $4.62 on Wednesday. The company has a quick ratio of 5.93, a current ratio of 5.93 and a debt-to-equity ratio of 0.06. The business has a 50 day moving average price of $5.17 and a 200 day moving average price of $5.15. The stock has a market cap of $557.89 million, a price-to-earnings ratio of -3.52 and a beta of 0.86. Exscientia plc has a fifty-two week low of $3.80 and a fifty-two week high of $7.91.

Exscientia (NASDAQ:EXAI) last released its earnings results on Thursday, August 15th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by ($0.05). The business had revenue of $5.60 million for the quarter. Exscientia had a negative return on equity of 37.56% and a negative net margin of 620.99%. Equities research analysts anticipate that Exscientia plc will post -1.25 earnings per share for the current fiscal year.

About Exscientia

Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. The company's lead product candidate GTAEXS617, a CDK7 inhibitor, which is currently in a Phase 1/2 trial to manage the potential toxicities associated with CDK7 as well as optimizing pharmacokinetics for maximizing on-target efficacy.